Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

Europe Colorectal Cancer Market to 2027 - Regional Analysis and Forecasts by Modality (Diagnosis Type, Therapy Type, Imaging Type); End User (Hospitals, Diagnostic and Research Laboratories), and Country

Published by The Insight Partners Product code 928814
Published Content info 229 Pages
Delivery time: 1-2 business days
Price
Back to Top
Europe Colorectal Cancer Market to 2027 - Regional Analysis and Forecasts by Modality (Diagnosis Type, Therapy Type, Imaging Type); End User (Hospitals, Diagnostic and Research Laboratories), and Country
Published: February 28, 2020 Content info: 229 Pages
Description

European colorectal cancer market, is anticipated to reach US$ 5,573.2 Mn in 2027 from US$ 4,241.2 Mn in 2019. The market is projected to grow with a CAGR of 3.5% from 2020-2027.

The colorectal cancer market is growing primarily due to the increasing prevalence of colorectal cancer, and benefits offered by generic drugs that are boosting the market over the years. Restraining factors, such as pricing pressure on drug manufacturers, are likely to damage the growth of the market in the coming years. On the other hand, rising healthcare expenditure in Europe is expected to have a positive impact on the growth of the Europe colorectal cancer market in the coming years.

Colorectal cancer is also known as colon cancer, bowel cancer, or rectal cancer. This type of cancer is the second leading cause of death in women and third in men. Colorectal cancer may be benign, or non-cancerous, or malignant. The symptoms shown by the patients who have colon cancer include changes in bowel habits, diarrhea or constipation, blood in stools that make it look black. Colorectal cancer can be treated with chemotherapy, radiotherapy, and surgery.

Colorectal cancer is one of the commonly found and lethal cancers which is developed in an individual with the combined influence of genetic and environmental factors. Additionally, according to the World Health Organization (WHO), colorectal cancer was the third most prevalent form of cancers, with approximately 1.80 million cases around the world in 2018, excluding skin cancer. The rates of colorectal cancer mortality and incidence vary across the globe as per the reports by WHO's cancer database GLOBOCAN. The GLOBOCAN reports approximately 861,000 deaths in 2018 due to colorectal cancer. The colorectal cancer is found among the significant population in the North American regions. For instance, according to the Centers for Disease Control and Prevention (CDC) and American Cancer Society, an estimated 145,600 adults in the United States were diagnosed, and 51,020 deaths were reported with colorectal cancer in 2018. The trend of the high presence of cancer is also similar in European countries. For instance, according to Cancer Research UK, deaths from bowel/colorectal cancer in the UK between 2015 and 2017 were reported to be 16,272. Moreover, the data also suggests approximately 42,000 new bowel cancer cases in the UK every year, which are more than 110 patients each day. Thus, the rising number of patients suffering with the disease is likely to drive the growth of colorectal cancer during the forecast period..

In 2019, the diagnosis type accounted for the largest market share in the Europe colorectal cancer market. The growth of diagnosis type is expected to grow due to rising colorectal screening programs and initiatives across the world. The diagnosis type segment is also estimated to mark the highest CAGR in the market during the forecast period, owing to the increasing technological development that is enabling the early detection of colorectal cancer by the various method of screenings.

In 2019, the hospitals segment held the most significant market share of the colorectal cancer market by the end user. This segment is also anticipated to hold a considerable portion of the market in 2027, owing to the need for hospitals as primary healthcare centers for the people. The segment is also anticipated to witness growth at a significant rate during the forecast period.

Some of the significant primary and secondary sources for colorectal cancer included in the report are Asociacion Espanola Contra El Cancer (AECC), Italian Association For Cancer Research (AIRC), Centre For The Development Of Industrial Technology (CDTI), European Commission Initiative On Colorectal Cancer (ECICC) and others.

Reasons to Buy

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe colorectal cancer market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the Europe colorectal cancer market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth regional market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Table of Contents
Product Code: TIPRE00009258

Table of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Europe Colorectal Cancer Market - By Modality
    • 1.3.2 Europe Colorectal Cancer Market - By End User
    • 1.3.3 Europe Colorectal Cancer Market - By Country

2. Europe Colorectal Cancer Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe Colorectal Cancer Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 Colorectal Cancer Market - Europe PEST Analysis

5. Europe Colorectal Cancer Market - Key Market Dynamics

  • 5.1 Key Market Drivers
    • 5.1.1 Increasing Prevalence Of Colorectal Cancer
    • 5.1.2 Benefits Offered By Generic Drugs
  • 5.2 Key Restraints
    • 5.2.1 Pricing Pressure On Drug Manufacturers
  • 5.3 Key Market Opportunities
    • 5.3.1 Rising Healthcare Expenditure in Europe
  • 5.4 Future Trend
    • 5.4.1 Inclination Towards Personalized Medicine
  • 5.5 Impact Analysis

6. Colorectal Cancer Market - Europe Analysis

  • 6.1 Europe Colorectal Cancer Market Revenue Forecasts and Analysis
  • 6.2 Positioning Of Key Players

7. Europe Colorectal Cancer Market Analysis And Forecasts To 2027 - Modality

  • 7.1 Overview
  • 7.2 Europe Colorectal Cancer Market, By Modality 2019 & 2027 (%)
    • 7.2.1 Europe Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
      • 7.2.1.1 Europe Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
      • 7.2.1.2 Europe Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 7.2.1.2.1 Europe Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 7.2.1.2.2 Europe Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
      • 7.2.1.3 Europe Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
  • 7.3 Diagnosis Type Market
    • 7.3.1 Overview
    • 7.3.2 Diagnosis Type Market Revenue and Forecast to 2027 (US$ Mn)
    • 7.3.3 Immunohistochemistry Market
      • 7.3.3.1 Overview
      • 7.3.3.2 Immunohistochemistry Market Revenue and Forecast to 2027 (US$ Mn)
    • 7.3.4 Stool Test Market
      • 7.3.4.1 Overview
      • 7.3.4.2 Stool Test Market Revenue and Forecast to 2027 (US$ Mn)
    • 7.3.5 Flexible Sigmoidoscopy Market
      • 7.3.5.1 Overview
      • 7.3.5.2 Flexible Sigmoidoscopy Market Revenue and Forecast to 2027 (US$ Mn)
    • 7.3.6 Colonoscopy Market
      • 7.3.6.1 Overview
      • 7.3.6.2 Colonoscopy Market Revenue and Forecast to 2027 (US$ Mn)
    • 7.3.7 CEA Test Market
      • 7.3.7.1 Overview
      • 7.3.7.2 CEA Test Market Revenue and Forecast to 2027 (US$ Mn)
    • 7.3.8 Other Test Market
      • 7.3.8.1 Overview
      • 7.3.8.2 Other Test Market Revenue and Forecast to 2027 (US$ Mn)
  • 7.4 Therapy Type Market
    • 7.4.1 Overview
    • 7.4.2 Therapy Type Market Revenue and Forecasts to 2027 (US$ Mn)
    • 7.4.3 Chemotherapy Market
      • 7.4.3.1 Overview
      • 7.4.3.2 Chemotherapy Market Revenue and Forecast to 2027 (US$ Mn)
      • 7.4.3.3 Alkylating Agent Market
        • 7.4.3.3.1 Overview
        • 7.4.3.3.2 Alkylating Agent Market Revenue and Forecast to 2027 (US$ Mn)
      • 7.4.3.4 Antimetabolites Market
        • 7.4.3.4.1 Antimetabolites Market Revenue and Forecast to 2027 (US$ Mn)
      • 7.4.3.5 Others Market
        • 7.4.3.5.1 Others Market Revenue and Forecast to 2027 (US$ Mn)
    • 7.4.4 Immunotherapy Market
      • 7.4.4.1 Overview
      • 7.4.4.2 Immunotherapy Market Revenue and Forecast to 2027 (US$ Mn)
      • 7.4.4.3 Panitumumab Market
        • 7.4.4.3.1 Overview
        • 7.4.4.3.2 Panitumumab Market Revenue and Forecast to 2027 (US$ Mn)
      • 7.4.4.4 Cetuximab Market
        • 7.4.4.4.1 Overview
        • 7.4.4.4.2 Cetuximab Market Revenue and Forecast to 2027 (US$ Mn)
      • 7.4.4.5 Bevacizumab Market
        • 7.4.4.5.1 Overview
        • 7.4.4.5.2 Bevacizumab Market Revenue and Forecast to 2027 (US$ Mn)
      • 7.4.4.6 Others Market
        • 7.4.4.6.1 Overview
        • 7.4.4.6.2 Others Market Revenue and Forecast to 2027 (US$ Mn)
    • 7.4.5 Chemoprotectant Market
      • 7.4.5.1 Overview
      • 7.4.5.2 Chemoprotectant Market Revenue and Forecast to 2027 (US$ Mn)
    • 7.4.6 Others Market
      • 7.4.6.1 Overview
      • 7.4.6.2 Others Market Revenue and Forecast to 2027 (US$ Mn)
  • 7.5 Imaging Type Market
    • 7.5.1 Overview
    • 7.5.2 Imaging Type Market Revenue and Forecasts to 2027 (US$ Mn)
    • 7.5.3 Computed Tomography (CT) Market
      • 7.5.3.1 Overview
      • 7.5.3.2 Computed Tomography (CT) Market Revenue and Forecast to 2027 (US$ Mn)
    • 7.5.4 Magnetic Resonance Imaging (MRI) Market
      • 7.5.4.1 Overview
      • 7.5.4.2 Magnetic Resonance Imaging (MRI) Market Revenue and Forecast to 2027 (US$ Mn)
    • 7.5.5 Others Market
      • 7.5.5.1 Overview
      • 7.5.5.2 Others Market Revenue and Forecast to 2027 (US$ Mn)

8. Europe Colorectal Cancer Market Analysis- By End User

  • 8.1 Overview
  • 8.2 Europe Colorectal Cancer Market, By End User 2019 & 2027 (%)
    • 8.2.1 Europe Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)
  • 8.3 Hospitals Market
    • 8.3.1 Overview
    • 8.3.2 Europe Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)
  • 8.4 Diagnostic and Research Laboratories Market
    • 8.4.1 Overview
    • 8.4.2 Europe Diagnostic and Research Laboratories Market Revenue and Forecasts to 2027 (US$ Mn)

9. Colorectal Cancer Market Revenue And Forecasts To 2027 - Geographical Analysis

  • 9.1 Europe Colorectal Cancer Market Revenue and Forecasts To 2027
    • 9.1.1 Overview
    • 9.1.2 Europe Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
    • 9.1.3 Europe Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
      • 9.1.3.1 Europe Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
      • 9.1.3.2 Europe Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.1.3.2.1 Europe Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.1.3.2.2 Europe Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
      • 9.1.3.3 Europe Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
    • 9.1.4 Europe Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)
    • 9.1.5 Europe Colorectal Cancer Market Revenue and Forecasts to 2027, By Country (%)
    • 9.1.6 Germany Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.1.6.1 Germany Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.1.6.2 Germany Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
        • 9.1.6.2.1 Germany Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.1.6.2.2 Germany Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.1.6.2.2.1 Germany Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.1.6.2.2.2 Germany Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.1.6.2.3 Germany Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
      • 9.1.6.3 Germany Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)
    • 9.1.7 UK Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.1.7.1 UK Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.1.7.2 UK Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
        • 9.1.7.2.1 UK Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.1.7.2.2 UK Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.1.7.2.2.1 UK Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.1.7.2.2.2 UK Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.1.7.2.3 UK Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
      • 9.1.7.3 UK Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)
    • 9.1.8 France Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.1.8.1 France Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.1.8.2 France Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
        • 9.1.8.2.1 France Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.1.8.2.2 France Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.1.8.2.2.1 France Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.1.8.2.2.2 France Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.1.8.2.3 France Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
      • 9.1.8.3 France Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)
    • 9.1.9 Spain Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.1.9.1 Spain Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.1.9.2 Spain Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
        • 9.1.9.2.1 Spain Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.1.9.2.2 Spain Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.1.9.2.2.1 Spain Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.1.9.2.2.2 Spain Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.1.9.2.3 Spain Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
      • 9.1.9.3 Spain Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)
    • 9.1.10 Italy Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.1.10.1 Italy Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.1.10.2 Italy Colorectal Cancer Market Revenue and Forecasts to 2027, By Modality (US$ Mn)
        • 9.1.10.2.1 Italy Diagnosis Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.1.10.2.2 Italy Therapy Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.1.10.2.2.1 Italy Chemotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.1.10.2.2.2 Italy Immunotherapy Market Revenue and Forecasts to 2027, By Type (US$ Mn)
        • 9.1.10.2.3 Italy Imaging Type Market Revenue and Forecasts to 2027, By Type (US$ Mn)
      • 9.1.10.3 Italy Colorectal Cancer Market Revenue and Forecasts to 2027, By End User (US$ Mn)

10. Europe Colorectal Cancer Market- Industry Landscape

  • 10.1 Overview
  • 10.2 Growth Strategies In The Colorectal Cancer Market, 2016-2019
  • 10.3 Organic Developments
    • 10.3.1 Overview
    • 10.3.2 Organic Growth Strategies In The Colorectal Cancer Market, 2016-2019
  • 10.4 Inorganic Developments
    • 10.4.1 Overview
    • 10.4.2 Inorganic Growth Strategies In The Colorectal Cancer Market, 2016-2019

11. Colorectal Cancer Market-Key Company Profiles

  • 11.1 Epigenomics AG
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Financial Overview
    • 11.1.4 Product Portfolio
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 Novigenix SA
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Financial Overview
    • 11.2.4 Product Portfolio
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 Clinical Genomics Technologies Pty Ltd.
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Financial Overview
    • 11.3.4 Product Portfolio
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 EDP Biotech Corporation
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Financial Overview
    • 11.4.4 Product Portfolio
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 Volitionrx Limited
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Financial Overview
    • 11.5.4 Product Portfolio
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments
  • 11.6 Abbott Laboratories
    • 11.6.1 Key Facts
    • 11.6.2 Business Description
    • 11.6.3 Financial Overview
    • 11.6.4 Product Portfolio
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Developments
  • 11.7 Amgen Inc.
    • 11.7.1 Key Facts
    • 11.7.2 Business Description
    • 11.7.3 Financial Overview
    • 11.7.4 Product Portfolio
    • 11.7.5 Pipeline (Clinical Trials) Portfolio
    • 11.7.6 SWOT Analysis
    • 11.7.7 Key Developments
  • 11.8 F. Hoffmann-La Roche AG
    • 11.8.1 Key Facts
    • 11.8.2 Business Description
    • 11.8.3 Financial Overview
    • 11.8.4 Product Portfolio
    • 11.8.5 Pipeline (Clinical Trials) Portfolio
    • 11.8.6 SWOT Analysis
    • 11.8.7 Key Developments
  • 11.9 Bruker Corporation
    • 11.9.1 Key Facts
    • 11.9.2 Business Description
    • 11.9.3 Financial Overview
    • 11.9.4 Product Portfolio
    • 11.9.5 SWOT Analysis
    • 11.9.6 Key Developments
  • 11.10 Quest Diagnostics Incorporated
    • 11.10.1 Key Facts
    • 11.10.2 Business Description
    • 11.10.3 Financial Overview
    • 11.10.4 Product Portfolio
    • 11.10.5 SWOT Analysis
    • 11.10.6 Key Developments
  • 11.11 Natera, Inc.
    • 11.11.1 Key Facts
    • 11.11.2 Business Description
    • 11.11.3 Financial Overview
    • 11.11.4 Product Portfolio
    • 11.11.5 SWOT Analysis
    • 11.11.6 Key Developments
  • 11.12 Guardant Health, Inc.
    • 11.12.1 Key Facts
    • 11.12.2 Business Description
    • 11.12.3 Financial Overview
    • 11.12.4 Product Portfolio
    • 11.12.5 SWOT Analysis
    • 11.12.6 Key Developments

12. Appendix

  • 12.1 About The Insight Partners
  • 12.2 Glossary of Terms

LIST OF TABLES

  • Table 1. Europe Colorectal Cancer Market Revenue and Forecasts To 2027, By Modality (US$ Mn)
  • Table 2. Europe Diagnosis Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 3. Europe Therapy Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 4. Europe Chemotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 5. Europe Immunotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 6. Europe Imaging Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 7. Europe Colorectal Cancer Market Revenue and Forecasts To 2027, By End User (US$ Mn)
  • Table 8. Europe Colorectal Cancer Market Revenue and Forecasts To 2027, By Modality (US$ Mn)
  • Table 9. Europe Diagnosis Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 10. Europe Therapy Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 11. Europe Chemotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 12. Europe Immunotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 13. Europe Imaging Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 14. Europe Colorectal Cancer Market Revenue and Forecasts To 2027, By End User (US$ Mn)
  • Table 15. Germany Colorectal Cancer Market Revenue and Forecasts To 2027, By Modality (US$ Mn)
  • Table 16. Germany Diagnosis Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 17. Germany Therapy Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 18. Germany Chemotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 19. Germany Immunotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 20. Germany Imaging Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 21. Germany Colorectal Cancer Market Revenue and Forecasts To 2027, By End User (US$ Mn)
  • Table 22. UK Colorectal Cancer Market Revenue and Forecasts To 2027, By Modality (US$ Mn)
  • Table 23. UK Diagnosis Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 24. UK Therapy Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 25. UK Chemotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 26. UK Immunotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 27. UK Imaging Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 28. UK Colorectal Cancer Market Revenue and Forecasts To 2027, By End User (US$ Mn)
  • Table 29. France Colorectal Cancer Market Revenue and Forecasts To 2027, By Modality (US$ Mn)
  • Table 30. France Diagnosis Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 31. France Therapy Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 32. France Chemotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 33. France Immunotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 34. France Imaging Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 35. France Colorectal Cancer Market Revenue and Forecasts To 2027, By End User (US$ Mn)
  • Table 36. Spain Colorectal Cancer Market Revenue and Forecasts To 2027, By Modality (US$ Mn)
  • Table 37. Spain Diagnosis Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 38. Spain Therapy Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 39. Spain Chemotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 40. Spain Immunotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 41. Spain Imaging Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 42. Spain Colorectal Cancer Market Revenue and Forecasts To 2027, By End User (US$ Mn)
  • Table 43. Italy Colorectal Cancer Market Revenue and Forecasts To 2027, By Modality (US$ Mn)
  • Table 44. Italy Diagnosis Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 45. Italy Therapy Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 46. Italy Chemotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 47. Italy Immunotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 48. Italy Imaging Type Market Revenue and Forecasts To 2027, By Type (US$ Mn)
  • Table 49. Italy Colorectal Cancer Market Revenue and Forecasts To 2027, By End User (US$ Mn)
  • Table 50. Recent Organic Growth Strategies In The Colorectal Cancer Market
  • Table 51. Recent Inorganic Growth Strategies In The Colorectal Cancer Market
  • Table 52. Glossary of Terms, Colorectal Cancer Market

LIST OF FIGURES

  • Figure 1. Colorectal Cancer Market Segmentation
  • Figure 2. Europe Colorectal Cancer Market Overview
  • Figure 3. Diagnosis Type Segment Held Largest Share Of Modality Segment In Colorectal Cancer Market
  • Figure 4. Germany Is Expected To Show Remarkable Growth During The Forecast Period
  • Figure 5. Europe Colorectal Cancer Market- Leading Country Markets (US$ Mn)
  • Figure 6. Europe colorectal Cancer Market, Industry Landscape
  • Figure 7. Colorectal Cancer Market - Europe PEST Analysis
  • Figure 8. Comparison of Brand - Name Drugs and Generic Drugs
  • Figure 9. Colorectal Cancer Market Impact Analysis of Drivers And Restraints
  • Figure 10. Europe Colorectal Cancer Market - Revenue Forecasts and Analysis - 2019- 2027
  • Figure 11. Market Positioning Of Key Player In Europe Colorectal Cancer Market
  • Figure 12. Europe Colorectal Cancer Market, by Modality 2019 & 2027 (%)
  • Figure 13. Diagnosis Type Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 14. Immunohistochemistry Market Revenue And Forecasts To 2027 (US$ MN)
  • Figure 15. Stool Test Market Revenue And Forecasts To 2027 (US$ MN)
  • Figure 16. Flexible Sigmoidoscopy Market Revenue And Forecasts To 2027 (US$ MN)
  • Figure 17. Colonoscopy Market Revenue And Forecasts To 2027 (US$ MN)
  • Figure 18. CEA Test Market Revenue And Forecasts To 2027 (US$ MN)
  • Figure 19. Other Test Market Revenue And Forecasts To 2027 (US$ MN)
  • Figure 20. Therapy Type Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 21. Chemotherapy Market Revenue And Forecasts To 2027 (US$ MN)
  • Figure 22. Alkylating Agent Market Revenue And Forecasts To 2027 (US$ MN)
  • Figure 23. Antimetabolites Market Revenue And Forecasts To 2027 (US$ MN)
  • Figure 24. Others Market Revenue And Forecasts To 2027 (US$ MN)
  • Figure 25. Immunotherapy Market Revenue And Forecasts To 2027 (US$ MN)
  • Figure 26. Panitumumab Market Revenue And Forecasts To 2027 (US$ MN)
  • Figure 27. Cetuximab Market Revenue And Forecasts To 2027 (US$ MN)
  • Figure 28. Bevacizumab Market Revenue And Forecasts To 2027 (US$ MN)
  • Figure 29. Others Market Revenue And Forecasts To 2027 (US$ MN)
  • Figure 30. Chemoprotectant Market Revenue And Forecasts To 2027 (US$ MN)
  • Figure 31. Others Market Revenue And Forecasts To 2027 (US$ MN)
  • Figure 32. Imaging Type Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 33. Computed Tomography (CT) Market Revenue And Forecasts To 2027 (US$ MN)
  • Figure 34. Magnetic Resonance Imaging (MRI) Market Revenue And Forecasts To 2027 (US$ MN)
  • Figure 35. Others Market Revenue And Forecasts To 2027 (US$ MN)
  • Figure 36. Europe Colorectal Cancer Market, by End User 2019 & 2027 (%)
  • Figure 37. Europe Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 38. Europe Diagnostic and Research Laboratories Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 39. Europe Colorectal Cancer Market Revenue Overview, By Country (2019) (US$ Mn)
  • Figure 40. Europe Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 41. Europe Colorectal Cancer Market Revenue and Forecasts to 2027, By Country (%)
  • Figure 42. Germany Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 43. UK Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 44. France Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 45. Spain Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 46. Italy Colorectal Cancer Market Revenue and Forecasts to 2027 (US$ Mn)
  • Figure 47. Growth Strategies In The Colorectal Cancer Market, 2016-2019
Back to Top